Department of Radiation Oncology, University of Tuebingen, Tuebingen, Germany.
Strahlenther Onkol. 2011 Nov;187(11):715-21. doi: 10.1007/s00066-011-2261-3. Epub 2011 Oct 29.
Multimodality treatment approaches provide high local control and satisfying overall survival (OS) for children with localized bladder and/or prostate rhabdomyosarcoma (BP-RMS). However, current strategies including surgery and conventional radiotherapy are compromised by high rates of long-term genitourinary adverse effects. Therefore, a planning study combining organ preserving surgery with three different innovative adjuvant radiotherapy approaches was performed.
A case of a 21-month-old boy with BP-RMS treated with polychemotherapy according to the CWS 2002-P protocol, prostatectomy, partial cystectomy, and adjuvant high dose rate brachytherapy (HDR-BT) was used to perform a planning study comparing HDR-BT with intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) planning.
All modalities provide good coverage of the target volume and spare critical normal tissues. Rectum doses could be reduced by 2/3 using IMPT and by 1/3 using BT compared to IMRT. In terms of sparing the pelvis growth plates, BT and IMPT are also superior to IMRT.
All modalities provide good sparing of normal tissue. BT and IMPT are superior to IMRT with regard to doses on rectum and growth plates. BT is equivalent to IMPT in adequately selected tumors.
多模态治疗方法为局限性膀胱和/或前列腺横纹肌肉瘤(BP-RMS)患儿提供了较高的局部控制率和满意的总生存期(OS)。然而,包括手术和常规放疗在内的现行策略因长期泌尿生殖系统不良影响的发生率较高而受到限制。因此,进行了一项联合保留器官手术和三种不同创新辅助放疗方法的规划研究。
采用 CWS 2002-P 方案对 1 例 21 个月大的 BP-RMS 患儿进行多药化疗,行前列腺切除术、部分膀胱切除术和辅助高剂量率近距离放疗(HDR-BT),利用该病例进行了一项规划研究,比较 HDR-BT 与调强放疗(IMRT)和调强质子治疗(IMPT)的计划。
所有方法均能很好地覆盖靶区,同时保护关键的正常组织。与 IMRT 相比,IMPT 和 BT 可将直肠剂量降低 2/3,降低 1/3。在保护骨盆生长板方面,BT 和 IMPT 也优于 IMRT。
所有方法均能很好地保护正常组织。BT 和 IMPT 在直肠和生长板剂量方面优于 IMRT。在适当选择的肿瘤中,BT 与 IMPT 等效。